103
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Demographic and clinical features of patients with substance-induced mental disorders admitted to the psychiatric hospital in Kermanshah, Iran

, , , , &
Pages 327-330 | Received 07 Nov 2014, Accepted 10 Mar 2015, Published online: 18 Sep 2015

References

  • Akiskal, H. S. (1995). Mood disorders: clinical features. In H. I. Kaplan & B. J. Sadock (Eds.), Comprehensive Textbook of Psychiatr (6th edn, Vol. 1, pp. 1123–1152). Baltimore, MA: Williams and Wilkins
  • Angrist, B. M., & Gershon, S. (1970). The phenomenology of experimentally induced amphetamine psychosis – Preliminary observations. Biological Psychiatry, 2, 95–107
  • Arseneault, L., Cannon, M., Witton, J., & Murray, R.M., (2004). Causal association between cannabis and psychosis: Examination of the evidence. The British Journal of Psychiatry, 184, 110–117
  • Bakken, K., Landheim, A. S., & Vaglum, P. (2003). Primary and secondary substance misusers: Do they differ in substance-induced and substance-independent mental disorders? Alcohol & Alcoholism, 38, 54–59
  • Bell, D. S. (1973). The experimental reproduction of amphetamine psychosis. Archives of General Psychiatry, 29, 35–40
  • Brooner, R. K., King, V. L., Kidorf, M., Schmidt, C. W, & Bigelow, G. E. (1997). Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry, 54, 71–80
  • Dalack, G. W., Healy, D. J., & Meador-Woodruff, J. H., (1998). Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings. The American Journal of Psychiatry, 155, 1490–1501
  • Harris, D., & Batki, S. L. (2000). Stimulant psychosis: Symptom profile and acute clinical course. American Journal on Addictions, 9, 28–37
  • Jafari, N., Abolhassani, F., Naghavi, M., Pourmalek, F., Moradi Lakeh, M., Kazemeini, H., & Kabir, M. J. (2009). National burden of disease and study in Iran. Iranian Journal of Public Health, 38, 71–73
  • Kadden, R. M., Kranzler, H. R., & Rounsaville, B. J. (1995). Validity of the distinction between “substance-induced” and “independent” depression and anxiety disorders. American Journal on Addictions, 4, 107–117
  • Kavanagh, D. J., McGrath, J., Saunders, J. B., Dore, G., & Clark, D. (2002). Substance misuse in patients with schizophrenia: Epidemiology and management. Drugs, 62, 743–55
  • Lehman, A. F., Myers, C. P., & Corty, E. C. (1989). Assessment and classification of patients with psychiatric and substance abuse syndromes. Hospital and Community Psychiatry, 40, 1019–1030
  • McKetin, R., McLaren, J., Lubman, D. I., & Hides, L. (2006). The prevalence of psychotic symptoms among methamphetamine users. Addiction, 101, 1473–1478
  • Mokri, A. (2002). Brief overview of the status of drug abuse in Iran. Archives of Iranian Medicine, 5, 184–190
  • Razzaghi, E. M., Rahimi Movaghar, A., Hosseini, M., & Madani, S. (1999). A Rapid Situation Assessment of Drug Abuse in Iran. Tehran:UNDCP
  • Srisurapanont, M., Ali, R., Marsden, J., Sunga, A., Wada, K., Monteiro, M. (2003). Psychotic symptoms in methamphetamine psychotic in-patients. International Journal of Neuropsychopharmacology, 6, 347–352
  • United Nations. (2007). World Drug Report 2007. New York: United Nations Office on Drugs and Crime Vienna
  • United Nations. (2008). World Drug Report 2008. New York: United Nations Office on Drugs and Crime Vienna
  • United Nations. (2009). World Drug Report 2009. New York: United Nations Office on Drugs and Crime Vienna
  • United Nations. (2010). World Drug Report 2010. New York: United Nations Office on Drugs and Crime Vienna
  • United Nations. (2011). World Drug Report 2011. New York: United Nations Office on Drugs and Crime Vienna
  • United Nations. (2012). World Drug Report 2012. New York: United Nations Office on Drugs and Crime Vienna
  • United Nations. (2013). World Drug Report 2013. New York: United Nations Office on Drugs and Crime Vienna
  • Williams, R., & Cohen, J. (2000). Substance use and misuse in psychiatric wards. Psychiatric Bulletin, 24, 43–46
  • Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002). Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study. British Medical Journal, 325, 1199
  • Zarghami, M. D. (2011). Methamphetamine has changed the profile of patients utilizing psychiatric emergency services in Iran. Iranian Journal of Psychiatry and Behavioral Sciences, 5, 1–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.